mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread. https://arstechnica.com/health/2026/08/mrna-cancer-vaccine-succeeded-in-phase-3-melanoma-trial-moderna-and-merck-say/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social
Comments (3)
Sign in to comment
@arstechnica Wonderful news! 🥳
@arstechnica
"Price" and "cost" give no return searching for them.
If you need to ask, you can't afford it?
@arstechnica will they now develop a vaccine to stop the communicable cancer killing Tasmanian devils? (They bite each other's faces a lot). Logical next step but no money in it. So I doubt it. Maybe if enough of the research wad open source someone will do it?